Healthcare · Medical - Diagnostics & Research
Price
$4.99
Market Cap
$3.8M
Employees
21
Beta
-0.04
Avg Volume
28,731
CEO
Alexander Y. Tokman
Business Description
ENDRA Life Sciences Inc. specializes in advancing the capabilities of clinical diagnostic ultrasound. The company's primary development is thermo-acoustic enhanced ultrasound technology, which operates by emitting sound waves that echo off internal body components such as tissues, organs, and blood. This innovation is utilized in managing nonalcoholic fatty liver disease, meticulously monitoring temperature during thermoablative surgical procedures, detailed vascular imaging, and assessing tissue perfusion. Furthermore, ENDRA offers other diagnostic imaging modalities, including computed tomography (CT), magnetic resonance imaging (MRI), and conventional ultrasound. These instruments empower physicians to visualize internal anatomy, aiding in treatment guidance and the identification of various medical conditions like bone fractures, cancerous growths, indicators of heart disease, or internal bleeding. The company also maintains a research collaboration agreement with General Electric Company. Established in 2007, ENDRA Life Sciences Inc. is headquartered in Ann Arbor, Michigan.
Business History
Price Overview
Last updated: Jun 27, 2026 9:03am (just now)$4.99
+0.69 (+16.05%)
Day Range
$4.47 – $5.30
52-Week Range
$2.96 – $11.96
50-Day MA
$5.09
200-Day MA
$4.92
Volume
158,537.00
Share Structure
Outstanding
752,631.00
Float
681,845.00
Free Float
90.6%
High free float
— 90.6% of shares trade freely, ~9.4% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Small absolute float (0.7M shares) — even with a decent free float %, volume can be thin. Check average daily volume before sizing a position.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-0.56
Stock Price: $4.99
EPS (Diluted): -8.93
EPS (Diluted): -8.93
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
1.56
Stock Price: $4.99
Total Equity: $2.26M
Shares: 787,020
Total Equity: $2.26M
Shares: 787,020
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
-0.54
Market Cap: $3.76M
Total Debt: $0.00
Cash: $762,365
EBITDA: -$6.87M
Total Debt: $0.00
Cash: $762,365
EBITDA: -$6.87M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$3.2M
Market Cap: $3.76M
Total Debt: $0.00
Cash: $762,365
Total Debt: $0.00
Cash: $762,365
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
0.00
Stock Price: $4.99
Revenue: $0.00
Shares: 787,020
Revenue: $0.00
Shares: 787,020
EV/Sales (Total value vs revenue — works when P/E can't)
API0.00
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
0.0%
Gross Profit: $0.00
Revenue: $0.00
Revenue: $0.00
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
0.0%
Operating Income: -$5.76M
Revenue: $0.00
Revenue: $0.00
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
0.0%
Net Income: -$7.03M
Revenue: $0.00
Revenue: $0.00
ROE (Profit from shareholder equity)
APINet Income / Total Equity
-513.2%
Net Income: -$7.03M
Total Equity: $2.26M
Total Equity: $2.26M
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
-236.3%
Operating Income: -$5.76M
Tax Rate: 0.0%
Equity: $2.26M
Total Debt: $0.00
Cash: $762,365
Tax Rate: 0.0%
Equity: $2.26M
Total Debt: $0.00
Cash: $762,365
Zero debt — invested capital = equity minus cash (very efficient)
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
1.29
Current Assets: $967,969
Current Liabilities: $750,956
Current Liabilities: $750,956
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.00
Short-Term Debt: $0.00
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $2.26M
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $2.26M
Zero debt — this company carries no debt obligations. Strongest possible score.
Rev/Share (Top-line per share)
Revenue / Shares Outstanding
—
Revenue: $0.00
Shares: 787,020
Shares: 787,020
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$2.87
Total Equity: $2.26M
Shares: 787,020
Shares: 787,020
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-6.61
Operating CF: -$5.18M
CapEx: -$17,280
Shares: 787,020
CapEx: -$17,280
Shares: 787,020
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $4.99
Stock Price: $4.99
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$7.03M
Net Income: -$7.03M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares NDRA against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 25, 2026 4:08pm (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Operating Expenses | $11.5M | $13.2M | $10.5M | $10.8M | $5.8M |
| Operating Income | -$11.5M | -$13.2M | -$10.5M | -$10.8M | -$5.8M |
| Net Income | -$11.2M | -$13.2M | -$10.1M | -$11.5M | -$7.0M |
| EBITDA | -$11.0M | -$12.9M | -$9.8M | -$11.3M | -$6.9M |
| EPS | $-5.47 | $-4.57 | $-5.89 | $-10.25 | $-8.93 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 25, 2026 4:08pm (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $9.5M | $4.9M | $2.8M | $3.2M | $762,365 |
| Total Current Assets | $12.1M | $8.5M | $3.0M | $3.4M | $967,969 |
| Total Assets | $12.9M | $9.3M | $6.8M | $4.5M | $3.9M |
| Current Liabilities | $1.5M | $1.7M | $903,095 | $605,230 | $750,956 |
| Long-Term Debt | $28,484 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.1M | $2.1M | $1.1M | $1.9M | $1.6M |
| Total Equity | $10.8M | $7.2M | $5.7M | $2.6M | $2.3M |
| Retained Earnings | -$68.7M | -$81.9M | -$91.9M | -$103.4M | -$110.5M |
Cash Flow (Annual)
Last updated: Jun 25, 2026 4:08pm (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$11.1M | -$12.8M | -$9.5M | -$7.4M | -$5.2M |
| Capital Expenditure | $-45,000 | $-202,577 | $-33,884 | $-16,000 | $-17,280 |
| Free Cash Flow | -$11.2M | -$13.0M | -$9.6M | -$7.4M | -$5.2M |
| Acquisitions (net) | $0 | $0 | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $2.2M | -$4.6M | -$2.1M | $395,573 | -$2.5M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 7:50am (1h ago)| Metric | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| Revenue |
$100,000 $100,000 – $100,000
|
$100,000 $100,000 – $100,000
|
$100,000 $100,000 – $100,000
|
$200,000 $200,000 – $200,000
|
| EBITDA | $0 | $0 | $0 | $0 |
| Net Income |
-$37.4M -$37.4M – -$37.4M
|
-$5.2M -$5.2M – -$5.2M
|
-$2.8M -$2.8M – -$2.8M
|
-$2.4M -$2.4M – -$2.4M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 25, 2026 4:08pm (1d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | — | — | — | — |
| Gross Profit Growth | — | — | — | — |
| Operating Income Growth | -14.4% | +20.0% | -2.8% | +46.7% |
| Net Income Growth | -17.3% | +23.7% | -14.4% | +38.9% |
| EBITDA Growth | -17.4% | +24.3% | -15.5% | +39.2% |
Insider Trading (Recent)
Last updated: Jun 27, 2026 7:50am (1h ago)
Type codes
PPurchase
SSale
AAward / grant
MOption exercise
FIn-kind (tax)
CConversion
GGift
DReturn to issuer
All SEC Form 4 codes
Open market
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
Compensation (Rule 16b-3)
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
Other exempt
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
Other
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-03-02 | Tokman Alexander Y | A-Award | 26,921.00 | $0.00 | $0 |
| 2026-03-02 | Jacroux Richard | A-Award | 13,461.00 | $0.00 | $0 |
| 2026-01-21 | DIGIANDOMENICO ANTHONY | A-Award | 60,324.00 | $0.00 | $0 |
| 2026-01-21 | Harsh Michael | A-Award | 60,324.00 | $0.00 | $0 |
| 2026-01-21 | Jacroux Richard | A-Award | 20,000.00 | $0.00 | $0 |
| 2026-01-21 | Basenese Lou | A-Award | 60,324.00 | $0.00 | $0 |
| 2026-01-21 | Tokman Alexander Y | A-Award | 75,000.00 | $0.00 | $0 |
| 2025-10-10 | DIGIANDOMENICO ANTHONY | A-Award | 141,644.00 | $6.81 | $964,596 |
| 2025-10-10 | DIGIANDOMENICO ANTHONY | A-Award | 70,822.00 | $7.06 | $500,003 |
| 2025-06-11 | Basenese Lou | A-Award | 5,384.00 | $0.00 | $0 |
| 2025-06-11 | Harsh Michael | A-Award | 5,384.00 | $0.00 | $0 |
| 2025-06-11 | DIGIANDOMENICO ANTHONY | A-Award | 5,384.00 | $0.00 | $0 |
| 2024-08-27 | UBS Group AG | P-Purchase | 0.00 | $0.00 | $0 |
| 2024-08-27 | UBS Group AG | P-Purchase | 3,715.00 | $0.55 | $2,052 |
| 2024-08-27 | UBS Group AG | 0.00 | $0.00 | $0 | |
| 2024-08-08 | Jacroux Richard | 0.00 | $0.00 | $0 | |
| 2024-01-02 | Basenese Lou | A-Award | 600.00 | $1.59 | $954 |
| 2024-01-02 | Harsh Michael | A-Award | 600.00 | $1.59 | $954 |
| 2024-01-02 | DIGIANDOMENICO ANTHONY | A-Award | 600.00 | $1.59 | $954 |
| 2024-01-02 | Tokman Alexander Y | A-Award | 600.00 | $1.59 | $954 |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for NDRA — it's generated by the pipeline (
market-narrative step).
No community reviews yet for NDRA.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30